NI201200041A -
FORMULATIONS IN TABLETS OF (4 '- TRIFLUOROMETHYLPHENYL) ACID AMIDE (Z) - 2 - CYAN - 3 - HYDROXIBUT - 2 - ENOIC WITH IMPROVED STABILITY
- Google Patents
FORMULATIONS IN TABLETS OF (4 '- TRIFLUOROMETHYLPHENYL) ACID AMIDE (Z) - 2 - CYAN - 3 - HYDROXIBUT - 2 - ENOIC WITH IMPROVED STABILITY
Info
Publication number
NI201200041A
NI201200041ANI201200041ANI201200041ANI201200041ANI 201200041 ANI201200041 ANI 201200041ANI 201200041 ANI201200041 ANI 201200041ANI 201200041 ANI201200041 ANI 201200041ANI 201200041 ANI201200041 ANI 201200041A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=69650477&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NI201200041(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis DeutschlandfiledCriticalSanofi Aventis Deutschland
Publication of NI201200041ApublicationCriticalpatent/NI201200041A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicinal Preparation
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se refiere a composiciones farmacéuticas sólidas que comprenden la ( 4' - trifluorometilfenil ) amida del ácido (Z) - 2 - ciano - 3 - hidroxibut - 2 - enoico, así como a procesos para su preparación, a métodos para utilizar dichas composiciones para tratar sujetos que padecen enfermedades autoinmunológicas, en partícular lupus eritematoso sistémico o enfermedad del injerto frente al receptor crónica, esclerosis múltiple o artritis reumatoide.The invention relates to solid pharmaceutical compositions comprising (Z) -2-cyano-3-hydroxybut-2-enoic acid (4'-trifluoromethylphenyl) amide, as well as to processes for their preparation, to methods of using said compositions for treating subjects suffering from autoimmune diseases, in particular systemic lupus erythematosus or chronic graft versus recipient disease, multiple sclerosis or rheumatoid arthritis.
NI201200041A2009-09-182012-03-13
FORMULATIONS IN TABLETS OF (4 '- TRIFLUOROMETHYLPHENYL) ACID AMIDE (Z) - 2 - CYAN - 3 - HYDROXIBUT - 2 - ENOIC WITH IMPROVED STABILITY
NI201200041A
(en)
Compounds derived from substituted benzoylamino-indan-2-carboxylic acids, inhibitors of the cxcr5 receptor; pharmaceutical composition; and its use in the treatment of inflammatory physiological effects, such as rheumatoid arthritis and asthma.
Compounds derived from polyunsaturated fatty acids; Preparation method; pharmaceutical composition comprising them; and its use for the prevention or treatment of cardiovascular, metabolic and inflammatory disorders, such as rheumatoid arthritis, atherosclerosis, diabetes, dyslipidemia, among others.
Compounds derived from oxazolopyrimidines, antagonists of the edg-1 receptor; preparation procedure; pharmaceutical composition; and use for the treatment of cardiovascular diseases, thrombosis, atherosclerosis, hypertension, diabetes, kidney, respiratory, inflammatory and autoimmune diseases, among others.
COMPOUNDS DERIVED FROM HETEROARIL-CARBOXAMIDA, ANTAGONISTS OF THE CHEMIOQUINE RECEPTOR; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OR PREVENTION OF SUCH DISEASES AS REJECTION OF ORGAN TRANSPLANTS, Rheumatoid Arthritis, LUPUS, ENTR